In line with these data, Lei and his colleagues documented decreased hepatic expression of PGC-1α, NRF1, and Tfam in the NAFLD human liver, suggesting a key role in mitochondrial biogenesis [37]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.